Modulation of lithium-pilocarpine-induced status epilepticus by adenosinergic agents

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 5, 1997, Pages 329-333

  George, B ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Adenosine; Lithium; Pilocarpine; Status epilepticus

Indexed keywords

2 CHLOROADENOSINE; 4' CHLORODIAZEPAM; ADENOSINE; CARBAMAZEPINE; CYCLOHEXYLADENOSINE; DIPYRIDAMOLE; LITHIUM; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; ELECTROSTIMULATION; ENZYME INHIBITION; EPILEPTIC STATE; HYPOGLYCEMIA; NEUROTRANSMITTER RELEASE; NONHUMAN; RAT;

2-CHLOROADENOSINE; ADENOSINE; ANIMALS; ANTICONVULSANTS; CARBAMAZEPINE; DIPYRIDAMOLE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LITHIUM; MALE; PILOCARPINE; RATS; RATS, WISTAR; STATUS EPILEPTICUS; THEOPHYLLINE; VASODILATOR AGENTS;

EID: 0030882990     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Samples, J.R., Janowsky, D.S. Penchnick, R., Judd, L.L. Lethal effects of physostigmine plus lithium in rats. Psychopharmacology 1977, 52: 307-9.
2. Honchar, M.P., Olney, J.W., Sherman, W.R. Systemic cholinergic agents induce seizures and brain damage in lithium treated rats. Science 1983, 220: 323-5.
3. George, B., Kulkarni, S.K. Protective effects of GABAergic drugs and other anticonvulsants in lithium-pilocarpineinduced status epilepticus. Meth Find Exp Clin Pharmacol 1996, 18(5): 335-40.
4. Marangos, P.J., Boulenger, J.P. Basic and clinical aspects of adenosinergic neuromodulation. Neurosci Biobehav Rev 1985, 9: 421-30.
5. Emerson, T.E., Raymond, R.M. Involvement of adenosine in cerebral hypoxia, hyperemia in the dog. Am J Physiol 1981, 241: H134-8.
6. Jonzon, B., Fredholm, B.B. Adenosine receptor mediated inhibition of noradrenaline release from slices of the rat hippocampus. Life Sci 1984, 35: 1971-9.
7. Daly, J.W. Adenosine receptors: Characterization with radioactive ligands. In: Physiology and Pharmacology of Adenosine Derivatives. Daly, J.W., Kuroda, Y., Phillis, J.W., Shimizu, H., Ui, M. (Eds.). Raven Press: New York 1983, 59-69.
8. Dunwiddie, T.V., Fredholm, B.B. Adenosine receptors mediating inhibitory electrophyswlogical responses in rat hippocampus are different from receptors mediating cyclic AMP accumulation. Naunyn Schmied Arch Pharmacol 1984, 326: 294-301.
9. 2-autoreceptor blockade. Br J Pharmacol 1987, 90: 403-12.
10. Ebstein, R.P., Daly, J.W. Release of norepinephrine and dopamine from brain vesicular preparations: Effects of adenosine analogues. Cell Mol Neurobiol 1982, 2: 193-204.
11. 2+ channels. Acta Physiol Scand 1998, 134: 119-26.
12. Terrian, D.M., Hernandez, P.G. Rea, M.A., Peters, R.I. ATP release, adenosine formation and modulation of dynorphin and glutamic acid release by adenosine analogues in rat hippocampal mossy fibre synaptosomes. J Neurochem 1989, 53: 1390-9.
13. Dunwiddie, T.V., Fredholm, B.B. Adenosine A receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus, J Pharmacol Exp Ther 1989, 249: 317.
14. Maitre, M., Ciesielski, L., Lehmann, A., Kempf, E., Mandel, P. Protective effect of adenosine and nicotinamide against audiogenic seizure. Biochem Pharmacol 1974, 23: 2807-16.
15. Dunwiddie, T.V., Worth, T. Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J Pharmacol Exp Ther 1982, 200: 70-6.
16. Winn, H.R., Rubio, G.R., Berne, R.M. The role of adenosine in the regulation of cerebral blood flow. J Cereb Blood Flow Metab 1981, 31: 1597-601.
17. Dragunow, M., Goddard, G.V. Adenosine modulation of amygdala kindling. Exp Neurol 1984, 84: 654-65.
18. Thorat, S.N., Kulkarni, S.K. The protective effect of adenosinergic agents, Ro 5-4864 and carbamazepine against Hypoxic stress-induced neurotoxicity in mice. Meth Find Exp Clin Pharmacol 1990, 12: 17-22.
19. Hagberg, H., Andersson, P., Butcher, S., Sandberg, M., Lehmann, A., Hamberger, A. Blockade of N-methyl-D-aspartate- sensitive acidic amino acid receptors inhibit ischemia induced accumulation of purine catabolites in the rat striatum. Neurosci Lett 1986, 311-6.
20. Dragunow, M., Faull, R.L.M. Neuroprotective effects of adenosine. Trends Pharmacol Sci 1988, 9: 193-4.
21. Rothman, S.M., Olney, J.W. Glutamate and the pathophysiology of hypoxic ischemic brain damage. Ann Neurol 1986, 19: 105-11.
22. Snyder, S.H. Adenosine receptors and the actions of methylxanthines. Trends Neurosci 1981, 4: 242-4.
23. 2+ channels. Eur J Pharmacol 1987, 134: 189-97.
24. I binding sites. Eur J Pharmacol 1989, 164: 399-401.
25. Thorat, S.N., Kulkarni, S.K. Modulatory effect of carbamaZepine on GABA-BZ receptor complex in mice. Psychopharmacology 1988, 96 (Suppl.): 206.
26. Marangos, P.J. Weiss, S.R.B., Montgomery, P. Chronic carbamazepine treatment increases brain adenosine receptors. Epilepsia 1985, 26: 493-8.